Influenza (pandemic)

Discovery points to a new path toward a universal flu vaccine

Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives.


RPT-Bird flu vaccine, under development, divides U.S. poultry industry

CHICAGO, June 8 (Reuters) - The death of more than 46 million chickens and turkeys in a bird flu outbreak is opening a rare fissure within the usually tight-knit U.S. poultry industry, pitting farmers with infected flocks against those who so far largely have sidestepped the worst outbreak in U.S. history.
At issue: whether to vaccinate poultry against the highly pathogenic bird flu virus.

The most predictable disaster in the history of the human race

Bill Gates is an optimist.

Ask him, and he'll tell you himself. "I'm very optimistic," he says. See?


U.S. government preps its response as another avian flu touches down

Amid the United States' battle with the current avian flu outbreak in poultry, the CDC on Wednesday announced plans to develop a vaccine to protect humans from a potential outbreak.
The virus--which has lead to the death of nearly 7 million birds since early last month--has had its most dramatic impact on commercial poultry in the Midwest. Though officials are "cautiously optimistic" that there won't be human cases, USA Today reported, the government routinely researches potential vaccines as a public health measure.

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to suspected deaths stemming from vaccination and some companies' (such as Shenzhen Kangtai, Tiantan Biological and Dalian Hissen) production halts of some products because of their failure to pass new GMP certification, China's human vaccine lot release volume in 2014 declined by 2.4% year on year to 791 million doses.

GSK recalls vaccine made at troubled plant in Canada

GlaxoSmithKline ($GSK) is recalling 1.7 million doses of its quadrivalent flu vaccine that was manufactured at a plant that ran into a series of manufacturing issues last year including an FDA warning letter. The company says there are questions about whether the vaccine is retaining its potency.

WHO: Several factors fueling surge of H5N1 in Egypt

In a monthly zoonotic flu update today, the World Health Organization (WHO) said it received reports seven more H5N1 avian flu cases that were not reported on Apr 9 by the WHO's Eastern Mediterranean regional office.
The recent Egyptian cases are some of the 42 H5N1 infections confirmed in March, 11 of them fatal, in Egypt, China, and Indonesia, most of which were previously reported.

Egypt’s Avian Flu Surge Lacks an Explanation

Cases of H5N1 avian flu have been surging in Egypt since the fall. Egypt has now passed Indonesia as the country with the most human cases in total since the virus was first found in Hong Kong almost 20 years ago.
About a third of the 336 cases Egypt has reported to the World Health Organization since 2006 have been fatal. H5N1 avian flu still has killed more people in Indonesia.

La confiance des médecins dans la vaccination, point clef pour l'application des recommandations vaccinales

Ces dernières années, un accroissement préoccupant d'opinions défavorables à la vaccination a été constaté dans la population générale en France. Plusieurs controverses ont eu lieu depuis la fin des années 1990 :
  • maladies neurodégénératives et vaccination contre l'hépatite B,
  • remise en cause de la vaccination contre la grippe pandémique A(H1N1)pdm09,
  • plaintes pénales à propos d'événements indésirables attribués à la vaccination contre les papillomavirus,
  • mise en cause de l'aluminium présent dans certains vaccins.